San Antonio Community Hospital (SACH) in Upland, California, and Masimo (Nasdaq: MASI), the inventor of Masimo rainbow Pulse CO-Oximetry™, Masimo rainbow Acoustic Monitoring™, and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, today jointly announced the completion of San Antonio Community Hospital's system-wide conversion to Masimo rainbow technology. The conversion ensures that all SACH patients will be monitored using the most technologically and clinically-advanced noninvasive patient monitoring technologies available—providing real-time measurement results for critical physiological parameters that help clinicians to more rapidly assess, diagnose, and treat patients.
"We converted our entire network to Masimo's advanced oximetry technology platform to give our clinical team the superior tools they need to provide the best clinical care possible and, after careful evaluation, it became clear that we would also be lowering our overall costs by implementing Masimo rainbow SET," stated Steven Moreau, President and CEO of San Antonio Community Hospital. "Staying on the forefront of medical technology advancements is just one of the ways SACH is staying true to our mission of providing outstanding healthcare in the community."
The system-wide conversion standardizes all of SACH's sites of care, including 279 hospital beds, to Masimo rainbow technology—the only upgradable pulse oximetry platform that allows hospitals to add breakthrough noninvasive blood constituent, hemodynamic, and respiration measurement capabilities that previously required invasive procedures. The ability to continuously and noninvasively measure total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), and acoustic respiration rate (RRa™), in addition to Masimo SET 'gold standard' Measure-Through Motion and Low Perfusion oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate (PR) measurements enables monitoring of multiple physiological parameters simultaneously—facilitating earlier detection and treatment of life-threatening conditions. The conversion involved upgrading virtually all of the hospital's multiparameter patient monitors, oximeters, and sensors to enable the new patient monitoring capabilities.
Perry Chu, MD, Anesthesiologist at San Antonio Community Hospital, stated, "Masimo's oximeters have proven to be the most sensitive and reliable, picking up saturation levels even in low perfusion states and when the patient is cold. I am particularly impressed with the Radical-7's ease-of-use, portability, and range of clinical utility as it affords us the unique ability to noninvasively monitor hemoglobin levels more closely and tightly."
Masimo Founder and CEO, Joe Kiani, stated, "San Antonio Community Hospital's conversion to the Masimo rainbow technology platform is proof positive of their commitment to offering the most advanced patient care throughout the Inland Empire."
Study finds lack of preventative care for children with sickle cell anemia